Clinical and laboratory features associated with myeloperoxidase expression in pediatric B-lymphoblastic leukemia.

Eric McGinnisDavid YangNicholas AuDouglas MorrisonKate M ChipperfieldAudi F SetiadiLorraine LiuAngela TsangSuzanne M Vercauteren

Published in: Cytometry. Part B, Clinical cytometry (2020)

In our study cohort, MPO+ B-ALL showed minimal residual disease persistence less often after induction chemotherapy but otherwise had similar clinical outcomes to MPO- B-ALL, with similar rates of additional myeloid antigen aberrancy.

Keyphrases

acute myeloid leukemia
bone marrow
dendritic cells
locally advanced
binding protein
radiation therapy
rectal cancer